Why Repligen Corporation’s (RGEN) Stock Is Down 8.48%
As of Friday, October 30, Repligen Corporation’s RGEN share price has dipped by 8.48%, which has investors questioning if this is right time to buy.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Michael Rose
Jenna Brashear
Rosalio Madrigal
| Share Statistics | RGEN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,725.8 | $3,704.0 | 79% |
|
| Shares Out (Mil) | 56.6 | 107.2 | 50% |
|
| Institutional Ownership | 99.8% | 89.2% | 94% |
|
| Float (Mil) | 61.0 | 83.6 | 51% |
|
| Beta | 1.08 | 1.14 | 64% |
|
| Avg Daily Volume (000s) | 1,014 | 1,029 | 68% |
|
| Price Change (52-week) |
6.2% | 84.8% | 56% |
|
| Growth | RGEN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.0% | 7.5% | 73% |
|
| Net Income (5yr) | (4.0%) | (12.1%) | 35% |
|
| EPS (5yr) | (5.0%) | 2.1% | 25 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (24.5%) | (14.9%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 17 | 20 | 19 | |
| Current EPS | $0.524 | $2.073 | $2.652 | |
| Month Ago EPS | $0.578 | $2.065 | $2.670 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $0.581 | $2.065 | $2.637 | |
| Year/Year Chg | (177.1%) | 141.0% | 299.5% | |
| Financials | RGEN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $806 | $811 | 47% |
|
| Net Income (TTM) (Mil) | ($12) | ($19) | 27% |
|
| EPS (TTM) | ($0.209) | ($0.300) | 32% |
|
| Operating Cash Flow (TTM) (Mil) | $130 | $52 | 54% |
|
| Net Cash Flow (TTM) (Mil) | ($20) | $3 | 28% |
|
| Long-Term Debt (Q1) (Mil) | $672 | $252 | 61% |
|
| Enterprise Value (Q1) (Mil) | $11,140 | $3,646 | 75% |
|
| Valuation | RGEN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.55 | 3.66 | 79% |
|
| P/E | na | 35.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 6.6 | na |
|
| Ratios | RGEN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 53.8% | 47.8% | 66% |
|
| Net Margin | (1.5%) | (3.0%) | 28% |
|
| ROA | (0.4%) | (5.4%) | 37% |
|
| ROE | (0.6%) | (5.2%) | 34% |
|
| Liabilities to Assets | 28.5% | 41.5% | 20% |
|
| F-Score | 6 | 5 | 67% |
|
Repligen Corporation did not pass any screens on 11/13/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors